Effects of Extracorporeal Circulation Techniques on Cerebral Perfusion in CABG Surgery
The Effects of Different Extracorporeal Circulation Techniques on Cerebral Perfusion Markers and Postoperative Awakening in Coronary Artery Bypass Graft Surgery
1 other identifier
observational
70
1 country
1
Brief Summary
This prospective study aims to compare the effects of minimal invasive extracorporeal circulation (MiECC) and conventional reservoir-based extracorporeal circulation techniques on cerebral perfusion in patients undergoing elective coronary artery bypass graft (CABG) surgery. Although the adverse effects of cardiopulmonary bypass on cerebral perfusion and oxygenation are well recognized, the relationship between these effects and changes in intracranial pressure has not been fully elucidated. In this context, ultrasonographic measurement of optic nerve sheath diameter (ONSD), a non-invasive surrogate marker of intracranial pressure, will be used in combination with near-infrared spectroscopy (NIRS) to enable a comprehensive assessment of cerebral perfusion and oxygenation. Between February 2026 and February 2027, a total of 70 ASA II-III patients scheduled for elective CABG surgery will be prospectively enrolled and allocated according to the extracorporeal circulation technique used. Perioperative ONSD measurements will be performed by a single anesthesiologist blinded to the perfusion technique. The primary endpoint is the comparison of perioperative changes in ONSD between the two techniques. Secondary endpoints include the correlation between ONSD and NIRS values, incidence of cerebrovascular events, extubation time, duration of intensive care unit and hospital stay, perioperative hemodynamic parameters, and postoperative complications. This study is expected to provide clinically relevant data on the cerebral effects of different extracorporeal circulation strategies and contribute to perioperative neuromonitoring practices in cardiac surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started May 2026
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 4, 2026
CompletedFirst Posted
Study publicly available on registry
February 19, 2026
CompletedStudy Start
First participant enrolled
May 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 1, 2027
February 19, 2026
February 1, 2026
1 year
February 4, 2026
February 11, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Perioperative Optic Nerve Sheath Diameter (ONSD)
Perioperative changes in optic nerve sheath diameter will be measured using ultrasonography to evaluate the effects of different extracorporeal circulation techniques on intracranial pressure-related cerebral perfusion.
Before initiation of cardiopulmonary bypass (CPB), during CPB, and immediately after completion of CPB (within the intraoperative period).
Secondary Outcomes (6)
Cerebral Oxygenation (NIRS)
From before induction of anesthesia through the intraoperative period until completion of anesthesia.
Correlation Between ONSD and NIRS
Correlation analysis performed using intraoperative ONSD and NIRS measurements obtained before CPB, during CPB, and after CPB within the intraoperative period
Incidence of Cerebrovascular Events
From completion of surgery to the occurrence of a postoperative cerebrovascular event or hospital discharge, whichever occurred first, assessed up to 30 postoperative days
Extubation Time
From completion of surgery to successful tracheal extubation in the intensive care unit, assessed up to 30 postoperative days.
Duration of Mechanical Ventilation
From completion of surgery to successful tracheal extubation in the intensive care unit, assessed up to 30 postoperative days.
- +1 more secondary outcomes
Study Arms (2)
Minimal Invasive Extracorporeal Circulation (MiECC) Group
Patients undergoing elective coronary artery bypass graft surgery using a minimal invasive extracorporeal circulation system. Cerebral perfusion will be assessed perioperatively using ultrasonographic optic nerve sheath diameter measurements and near-infrared spectroscopy monitoring.
Conventional Extracorporeal Circulation (cECC) Group
Patients undergoing elective coronary artery bypass graft surgery using a conventional reservoir-based extracorporeal circulation system. Perioperative cerebral perfusion will be evaluated using ultrasonographic optic nerve sheath diameter measurements and near-infrared spectroscopy monitoring.
Eligibility Criteria
The study population consists of adult patients aged 18 years and older with American Society of Anesthesiologists (ASA) physical status II-III who are scheduled to undergo elective coronary artery bypass graft surgery with the use of extracorporeal circulation. All participants will be treated according to standard clinical practice in a tertiary cardiac surgery center and will provide written informed consent prior to enrollment.
You may qualify if:
- Age ≥ 18 years
- Scheduled for elective coronary artery bypass graft (CABG) surgery
- American Society of Anesthesiologists (ASA) physical status II-III
- Planned use of extracorporeal circulation during surgery
- Ability to provide written informed consent
You may not qualify if:
- Age \< 18 years
- ASA physical status other than II-III
- Emergency surgery
- Pregnancy
- History of neurological disease affecting consciousness or decision-making capacity
- History of psychiatric disease affecting decision-making capacity
- History of head trauma within the previous 24 hours
- Presence of carotid artery stenosis or significant carotid artery disease
- Coagulation disorders (INR \> 1.25, aPTT \> 35 s, or platelet count \< 100,000/μL)
- Reoperation (redo cardiac surgery)
- Congestive heart failure
- Chronic kidney failure
- Sepsis
- Hypoxia
- Ocular trauma
- +1 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kosuyolu High Specialization Training and Research Hospital
Istanbul, 34870, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mustafa Burgaç
mustafaburgac@outlook.com
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Specialist physician
Study Record Dates
First Submitted
February 4, 2026
First Posted
February 19, 2026
Study Start
May 1, 2026
Primary Completion (Estimated)
May 1, 2027
Study Completion (Estimated)
May 1, 2027
Last Updated
February 19, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share
Individual participant data collected during this study will not be shared. Aggregate study results may be presented in publications. Additional documents such as the study protocol or statistical analysis plan may be made available upon reasonable request to the corresponding author, in accordance with institutional and journal policies.